Loading…
Drug Policy Reform Act of 2021
Legislative Progress
Introduced
June 17, 2021
Latest Action
November 1, 2022
Primary Sponsor
Bonnie Watson ColemanDemocratic(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
502d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Drug Policy Reform Act of 2021 or the DPR Act of 2021 This bill transfers federal regulatory authority over controlled substances, eliminates federal penalties for some drug-related offenses, and removes some collateral consequences for certain criminal convictions. A collateral consequence is a penalty (e.g., a restriction on access to a program or service) imposed on an individual in addition to the penalty associated with the sentence. Specifically, the bill transfers regulatory authority over controlled substances from the Department of Justice to the Department of Health and Human Services (HHS). Additionally, the bill directs HHS to establish a commission to determine a benchmark amount of a controlled substance for personal use supply. The bill eliminates federal criminal and civil penalties for simple possession of a controlled substance in an amount equal to or less than the benchmark. Finally, the bill removes the collateral consequences of certain convictions. For example, the bill removes some restrictions on eligibility for federal assistance and benefits for individuals who are convicted of certain drug-related offenses, reinstates the right to vote in federal elections for persons convicted of criminal offenses, and repeals the requirement for states to revoke or suspend driver's licenses of individuals who are convicted of drug offenses as a condition of receiving a full allocation of certain federal grant funds.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2022 · second_quarter · Law Enforcement/Crime/Criminal Justice
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
Referred to the Subcommittee on Highways and Transit.
Referred to the Subcommittee on Health.
Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions. Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Law Enforcement/Crime/Criminal Justice
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Law Enforcement/Crime/Criminal Justice
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Law Enforcement/Crime/Criminal Justice
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Law Enforcement/Crime/Criminal Justice
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Law Enforcement/Crime/Criminal Justice
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Law Enforcement/Crime/Criminal Justice
Lobbied the Senate to make improvements to the Justice in Policing Act (HR 1280), a federal policing bill. Lobbied on behalf of the FAIR Act(HR 2857) to end civil asset forfeiture. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Referred to |
| June 17, 2021 |
| Armed Services Committee | House | Referred to | June 17, 2021 |
| Committee on House Administration | House | Referred to | June 17, 2021 |
| Financial Services Committee | House | Referred to | June 17, 2021 |
| Oversight and Accountability Committee | House | Referred to | June 17, 2021 |
| Democratic |
| CA |
| Bennie G. Thompson | Democratic | MS |
| Cori Bush | Democratic | MO |
| Diana DeGette | Democratic | CO |
| Earl Blumenauer | Democratic | OR |
| Eleanor Holmes Norton | Democratic | DC |
| Gwen Moore | Democratic | WI |
| Ilhan Omar | Democratic | MN |
| J. Luis Correa | Democratic | CA |
| Jamaal Bowman | Democratic | NY |
| James P. McGovern | Democratic | MA |
| Janice D. Schakowsky | Democratic | IL |
| Jesús G. "Chuy" García | Democratic | IL |
| Mondaire Jones | Democratic | NY |
| Rashida Tlaib | Democratic | MI |